Orient Pharma Co., Ltd. (TPEX:4166)

FARO Technologies Revenue

Orient Pharma had revenue of 316.90M TWD in the quarter ending March 31, 2025, with 14.84% growth. This brings the company's revenue in the last twelve months to 1.26B, up 32.72% year-over-year. In the year 2024, Orient Pharma had annual revenue of 1.22B with 37.41% growth.

• Revenue (ttm): 1.26B
• Revenue Growth: +32.72%
• P/S Ratio: 5.67
• Revenue / Employee: 7.31M
• Employees: 173
• Market Cap: 7.17B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.22B	332.90M	37.41%
Dec 31, 2023	889.91M	378.05M	73.86%
Dec 31, 2022	511.86M	48.52M	10.47%
Dec 31, 2021	463.34M	51.33M	12.46%
Dec 31, 2020	412.01M	58.47M	16.54%